Unichem Laboratories Share Price

Unichem Laboratories Share Price

NSE: UNICHEMLAB
|
Pharmaceuticals
|
S Cap
₹ 573.20
+₹34.45 (6.39%)
1D
Last updated 23 Sep, 2026, 15:57 IST

Unichem Laboratories Share Price Today

As of 24 Sep 2026, Unichem Laboratories share price is ₹573.20. The stock opened at ₹539.00, compared to its previous close of ₹538.75. During today's trading session, Unichem Laboratories share price moved in the range of ₹539.00 to ₹576.00, with an average price of ₹557.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹278.20 and a high of ₹687.20. On the performance front, Unichem Laboratories share price has increased by 90.65% over the last six months and is up 15.87% on a year-on-year basis.

₹539.00
6.39% up today
₹576.00
1D LOW
1D HIGH

Unichem Laboratories Returns Calculator

Circuit
L
H
₹458.60
₹687.80
52-week
L
H
₹278.20
₹687.20

About Unichem Laboratories

Unichem Laboratories Share Price
ISIN
INE351A01035
Sector Market Cap
₹ 4,033.90 Cr

Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.

Unichem Laboratories Financial Highlights

  • Revenue: Unichem Laboratories reported revenue of ₹2,264.91 crore in FY26 vs ₹2,146.29 crore in FY25. It showed an increase of 5.53% on a yearly basis.
  • Operating Profit: Unichem Laboratories reported an operating profit of ₹292.38 crore in FY26 vs ₹154.59 crore in FY25. It showed an increase of 89.13% on a year-on-year basis.
  • Net Profit: Unichem Laboratories reported a net profit of ₹252.84 crore in FY26 vs ₹137.52 crore in FY25. It showed an increase of 83.86% on a yearly basis.

Unichem Laboratories Quarterly Result Highlights

  • Unichem Laboratories reported revenue of ₹648.23 crore in Jun 2026, compared with ₹598.59 crore in Mar 2026, representing an increase of 8.29% on a quarter-on-quarter (QoQ) basis.
  • Unichem Laboratories reported an operating profit of ₹48.99 crore in Jun 2026, compared with ₹18.79 crore in Mar 2026, representing an increase of 160.72% on a quarter-on-quarter (QoQ) basis.
  • Unichem Laboratories reported a profit of ₹41.47 crore in Jun 2026, compared with ₹10.91 crore in Mar 2026, reflecting an increase of 280.11% on a QoQ basis.
  • The earnings per share (EPS) of Unichem Laboratories stood at ₹35.91 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
70.22%
FII
0.91%
Other DII
1.14%
Retail and other
18.42%
Mutual funds
9.32%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20251.00%
Dec 20250.99%
Mar 20261.00%
Jun 20260.91%
Mkt Cap Cr
3,764.24
P/E
13.24
P/B
1.48
ROE
2.88%
D/E
0.02
ROCE
3.79%
Div. Yield
0.00%
EPS(TTM)
22.57
Turnover
0.45
EV/EBITDA
7.91
Net Margin
-1.10%
Op. Margin
8.19%
ROA
8.15%
Quick Ratio
2.99
Curr. Ratio
5.12
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Unichem Labs. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Unichem Labs. appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Unichem Labs. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.935.3513.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0087.1015.2015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0087.8622.5325.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.404.3018.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.223.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.00100.8320.7416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,01,712.0049.196.2411.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.732.6511.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.752.629.25%0.1911.76%394.820.24%0.3841.58
Lupin96,030.9017.304.2823.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Unichem Laboratories Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,201.85₹2,110.97₹1,785.11₹1,343.02
Other Income₹63.06₹35.32₹31.59₹38.52
Total Revenue₹2,264.91₹2,146.29₹1,816.70₹1,381.54
Total Expenses₹2,174.39₹1,991.70₹1,844.05₹1,519.33
Profit Before Tax₹292.38₹154.59-₹84.96-₹176.36
Tax₹39.54₹17.07₹8.80₹25.86
Profit After Tax₹252.84₹137.52-₹93.76-₹202.23
EPS - Basic₹35.91₹19.53-₹13.32-₹28.72
EPS - Diluted₹35.85₹19.47-₹13.32-₹28.72

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹292.38₹154.59-₹84.96-₹176.36
Income before WC changes₹219.34₹303.29₹112.36-₹43.52
Change in Assets-₹7.11-₹291.52-₹84.84-₹148.62
Change in Liabilities-₹201.02-₹2.37-₹7.15₹119.26
Change in WC-₹208.13-₹293.89-₹91.99-₹29.36
Cash flow from Operations₹3.64-₹7.02₹14.00-₹85.09
Cash flow from Investing₹192.06-₹241.23₹50.40₹202.81
Cash flow from Financing₹1.86₹183.76-₹106.31-₹81.30
Total Cash Flow₹197.56-₹64.49-₹41.91₹36.42
Cash (Start of the year)₹89.58₹154.75₹183.75₹109.20
Cash (End of the year)₹289.48₹89.58₹154.75₹183.75

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,540.10₹1,539.93₹1,531.63₹1,604.58
Current Assets₹2,197.34₹2,029.47₹1,743.32₹1,588.47
Total Assets₹3,737.44₹3,569.40₹3,274.95₹3,193.05
Current Liabilities₹885.94₹991.97₹737.60₹639.60
Net Current Asset₹1,311.40₹1,037.50₹1,005.72₹948.86
Non-Current Liabilities₹134.06₹126.84₹99.05₹118.14
Equity Capital₹2,717.44₹2,450.59₹2,438.30₹2,435.30
Total Equity & Liabilities₹3,737.44₹3,569.40₹3,274.95₹3,193.05

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,412.29₹1,735.70₹1,442.16₹1,072.43
Other Income₹62.90₹40.83₹30.39₹41.85
Total Revenue₹1,475.19₹1,776.53₹1,472.55₹1,114.28
Total Expenses₹1,492.76₹1,597.85₹1,507.12₹1,280.71
Profit Before Tax₹209.41₹182.68-₹92.18-₹279.09
Tax₹50.47₹19.72₹0.00₹20.61
Profit After Tax₹158.94₹162.96-₹92.18-₹299.70
EPS - Basic₹22.57₹23.15-₹13.09-₹42.57
EPS - Diluted₹22.53₹23.08-₹13.09-₹42.57

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹209.41₹182.68-₹92.18-₹279.09
Income before WC changes₹82.25₹289.98₹73.20-₹75.79
Change in Assets₹178.51-₹220.23-₹76.80-₹141.73
Change in Liabilities-₹208.50₹2.82-₹37.82₹100.28
Change in WC-₹29.99-₹217.41-₹114.62-₹41.45
Cash flow from Operations₹52.60₹72.29-₹41.57-₹117.33
Cash flow from Investing₹207.81-₹174.94₹53.24₹202.50
Cash flow from Financing-₹70.66₹38.26-₹48.06-₹61.76
Total Cash Flow₹189.75-₹64.39-₹36.39₹23.41
Cash (Start of the year)₹60.58₹125.65₹155.67₹94.13
Cash (End of the year)₹252.67₹60.58₹125.65₹155.67

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,558.80₹1,542.87₹1,457.57₹1,593.38
Current Assets₹1,533.65₹1,566.34₹1,383.94₹1,292.76
Total Assets₹3,092.45₹3,109.21₹2,841.51₹2,886.14
Current Liabilities₹314.96₹519.53₹465.75₹388.66
Net Current Asset₹1,218.69₹1,046.81₹918.19₹904.10
Non-Current Liabilities₹150.39₹129.93₹81.13₹113.21
Equity Capital₹2,627.10₹2,459.75₹2,294.63₹2,384.27
Total Equity & Liabilities₹3,092.45₹3,109.21₹2,841.51₹2,886.14
* All values are in INR Crore
Qty
Bid
475
573.2
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 475
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
4
Neutral
3
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
60.5
Neutral
ATR (14)
27.84
Neutral
STOCH(9,6)
96.42
Bearish
STOCH RSI (14)
99.93
Bearish
ADX(9)
22.1
Bearish
UO(9)
50.14
Neutral
ROC(12)
4.18
Bullish
WillR(14)
-19.32
Bearish
Period
Simple value
Exponential vaue
5D
547.35
550.25
10D
539.52
545.53
20D
546.28
542.63
50D
540.02
527.64
100D
482.35
493.31
Volume trend — traded volume by day
23 Sep2L
22 Sep1L
21 Sep0L
18 Sep0L
17 Sep0L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Unichem Laboratories Share Price
Unichem Laboratories
Pharmaceuticals
Add Stock
Add Another

Unichem Laboratories Share Price FAQs

Unichem Laboratories share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837